Estimated read time: 5 minutes

Clinical decision support earns trust in 2026 when a clinician can see why a tool recommends what it does. FDA's Clinical Decision Support Software guidance, issued in January 2026, keeps that idea at the center. The same quality, a visible basis, is what makes a health-tech company's public claims credible to buyers and to AI answers.

This is for leaders of health-tech companies that build decision support, and for practice and hospital leaders who buy it. You get the four criteria FDA applies, what they mean for product design, how to fit a tool into clinical work, and how to describe it so it can be found and cited.

1. Read the four criteria FDA applies

FDA's Clinical Decision Support Software guidance explains when software falls outside the definition of a device under section 520(o)(1)(E) of the FD&C Act. The software is not intended to analyze a medical image, a signal from an in vitro diagnostic device, or a pattern or signal from a signal acquisition system.

It displays or analyzes medical information, such as patient data, peer-reviewed studies, or clinical practice guidelines. It supports or provides recommendations to a health care professional about prevention, diagnosis, or treatment.

And it enables that professional to independently review the basis for the recommendations, so they do not rely primarily on the software to make a decision for an individual patient.

Whether a specific product meets these criteria is a question for regulatory counsel and FDA. For everyone else, the criteria work as a design brief.

2. Design for review, not reliance

The fourth criterion is a design requirement in plain clothes. Show the inputs behind a recommendation, the guideline or study it draws on, and the logic in plain language, at the moment the clinician decides.

FDA's guidance names the risk this addresses. Automation bias is the propensity to over-rely on a suggestion from an automated system. FDA notes it can produce errors of commission, following incorrect advice, and errors of omission, failing to act because no prompt appeared. It increases when action is urgent.

Show what the tool did not know, such as missing labs or an incomplete history. Record each override and its reason, and review those records with clinical leadership on a set schedule.

Reserve interruptive alerts for urgent situations. Everything else can sit where a clinician looks for it.

3. Fit the tool where clinicians already work

A recommendation that lives behind a separate login gets skipped. Place it inside the record system, at the step where the decision happens, with the basis one click away.

Pilot with a small group of clinicians first. Measure how often the tool is used, how often it is overridden and why, and whether the outcome it targets moves. Expand in stages, and keep the measures running after rollout.

Give the program a clinical owner. Train staff on what the tool considers, what it ignores, and when to question it. Adoption follows trust, and trust follows a basis people can check.

4. Publish the basis where buyers and AI can read it

Buyers ask the same questions clinicians do. What does it recommend? Based on what evidence? Validated where, and with whom? What is its regulatory status? Answer each one on a public page, in text, with sources linked.

Google says its systems give even more weight to content with strong experience, expertise, authoritativeness, and trust on topics that could significantly affect people's health, and that trust is most important. It also asks whether content shows clear sourcing and background about the author or site.

Google states there are no special optimizations or schema required to appear in AI Overviews or AI Mode, beyond being indexed and eligible for a snippet. ChatGPT search relies on OpenAI's OAI-SearchBot, separate from GPTBot. Confirm your robots.txt allows what you intend for each.

Then ask AI services the questions your buyers ask, and log the answers and cited pages monthly. A citation shows what an answer said that day. It does not prove why. This is Authority and Citation in the Trust Triangle: a sourced page gives the answer something true to repeat.

Show the basis, earn the recommendation

Clinical decision support in 2026 is judged by how well it shows its reasoning. FDA's criteria ask for it. Clinicians adopt tools that offer it. AI answers cite pages that state it clearly.

Get found with a page that explains the basis. Get recommended by claiming only what the evidence supports. Get cited by being the source that shows its work.

This article contains affiliate links. I may earn a commission if you purchase through them, at no additional cost to you.

Stay in touch

Keep Reading